Stefania Irina Dumitrel

Mrs. Stefania Irina Dumitrel

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
ASAndreea Smeu
Andreea Smeu
Iasmina MarcoviciIasmina Marcovici
Iasmina Marcovici
CRISTINA ADRIANA DEHELEANCRISTINA ADRIANA DEHELEAN
CRISTINA ADRIANA DEHELEAN
SDStefania Irina Dumitrel
Stefania Irina Dumitrel
CBClaudia Borza
Claudia Borza
RLRodica Lighezan
Rodica Lighezan
Colorectal cancer (CRC) represents one of the most serious health issues and the third most commonly diagnosed cancer worldwide. However, the treatment options for CRC are associated with adverse reactions, and in some cases, resistance can develop. Flavonoids have emerged as promising alternatives for CRC prevention and therapy due to their multitude of biological properties and ability to target distinct processes involved in CRC pathogenesis. Their innate disadvantageous properties (e.g., low solubility and stability, reduced bioavailability, and lack of tumor specificity) have delayed the potential inclusion of flavonoids in CRC treatment regimens but have hastened the design of nanopharmaceuticals comprising a flavonoid agent entrapped in a nanosized delivery platform that not only counteract these inconveniences but also provide an augmented therapeutic effect and an elevated safety profile by conferring a targeted action. Starting with a brief presentation of the pathological features of CRC and an overview of flavonoid classes, the present study comprehensively reviews the anti-CRC activity of different flavonoids from a mechanistic perspective while also portraying the latest discoveries made in the area of flavonoid-containing nanocarriers that have proved efficient in CRC management. This review concludes by showcasing future perspectives for the advancement of flavonoids and flavonoid-based nanopharmaceuticals in CRC research.

10 August 2024 in Molecules
Verified
Journal Article
Open access
PDF file
SDStefania Irina Dumitrel
Stefania Irina Dumitrel
AMAnamaria Matichescu
Anamaria Matichescu
Stefania DinuStefania Dinu
Stefania Dinu
RBRoxana Buzatu
Roxana Buzatu
RPRamona Amina Popovici
Ramona Amina Popovici
DBDana Cristina Bratu
Dana Cristina Bratu
Worldwide, synthetic compounds are used for both in-office and at-home dental care. They are a valuable resource for both prophylactic and curative treatments for various dental problems, such as tooth decay, periodontal diseases, and many more. They are typically preferred due to their broad range of actions and ability to produce targeted, rapid, and long-lasting effects. Using a 0.12% chlorhexidine mouthwash is capable of reducing the plaque index from 47.69% to 2.37% and the bleeding index from 32.93% to 6.28% after just 2 weeks. Mouthwash with 0.1% OCT is also highly effective, as it significantly lowered the median plaque index and salivary bacterial counts in 152 patients in 5 days compared to a control group (p < 0.0001), while also reducing the gingival index (p < 0.001). When povidone-iodine was used as an irrigant during the surgical removal of mandibular third molars in 105 patients, it resulted in notably lower pain scores after 2 days compared to a control group (4.57 ± 0.60 vs. 5.71 ± 0.45). Sodium hypochlorite is excellent for root canal disinfection, as irrigating with 1% NaOCl completely eliminated the bacteria from canals in 65% patients. A 0.05% CPC mouthwash proved effective for perioperative patient care, significantly decreasing gingival bleeding (p < 0.001) and suppressing Streptococcus levels even one week post-surgery. Lastly, a 6% H2O2 paint-on varnish and 6% H2O2 tray formulations successfully bleached the teeth of 40 patients, maintaining a noticeably whiter appearance up to the 6-month follow-up, with significant color differences from the baseline (p < 0.005). Synthetic compounds have a large research base, which also provides a greater awareness of their mechanism of action and potential adverse effects. For a better understanding of how they work, several methods and assays are performed. These are protocolary techniques through which a compound’s efficacy and toxicity are established.

24 July 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
CRISTINA ADRIANA DEHELEANCRISTINA ADRIANA DEHELEAN
CRISTINA ADRIANA DEHELEAN
CBCasiana Boru
Casiana Boru
IMIoana Macasoi
Ioana Macasoi
SDStefania Irina Dumitrel
Stefania Irina Dumitrel
CTCristina Trandafirescu
Cristina Trandafirescu
Ersilia AlexaErsilia Alexa
Ersilia Alexa
Background/Objectives: As an essential polyunsaturated fatty acid, linoleic acid (LA) plays an important role in maintaining the integrity of cellular membranes, modulating inflammatory responses, and mediating intracellular signaling. This review explores the structure, properties, and nutritional significance of LA and its bioactive derivatives, with particular attention to sustainable production methods and their potential applications. Methods: A comprehensive review of the recent literature was conducted, emphasizing the use of green synthesis techniques, such as enzyme-catalyzed biocatalysis and microbiological transformations, in order to obtain LA-derived nutraceuticals. Analyses were conducted on the key aspects related to food industry applications, regulatory frameworks, and emerging market trends. Results: Through green synthesis strategies, LA derivatives with antioxidant, anti-inflammatory, and antimicrobial properties have been developed. There is potential for these compounds to be incorporated into health-oriented food products. In spite of this, challenges remain regarding their stability and bioavailability. Furthermore, there are inconsistencies in international regulatory standards which prevent these compounds from being widely adopted. Conclusions: The development of functional and sustainable food products based on linoleic acid derivatives obtained using ecological methods offers significant potential. Research is required to optimize production processes, enhance compound stability, and clinically validate health effects. The integration of the market and the safety of consumers will be supported by addressing regulatory harmonization.

12 February 2026 in Dentistry Journal
Verified
Journal Article
Open access
PDF file
DNDiana Nica
Diana Nica
MCMioara Raluca Cosoroaba
Mioara Raluca Cosoroaba
Stefania DinuStefania Dinu
Stefania Dinu
SDStefania Irina Dumitrel
Stefania Irina Dumitrel
DCDoina Chioran
Doina Chioran
MPMalina Popa
Malina Popa
Background/Objectives: Thymol (THY) is widely used in oral care products for its antimicrobial and anti-inflammatory activity, but data on its cytocompatibility, potential differential effects on oropharyngeal-derived cells, and mucosal irritation under prolonged exposure remain limited. This study evaluated THY’s effects on healthy human gingival fibroblasts (HGF-1) and pharyngeal carcinoma (Detroit-562) cells after 24 h exposure, together with its irritation potential in ovo. Methods: Cells were treated with THY (100–300 µM) for 24 h. Cellular viability (MTT), morphology, mitochondrial alterations (MitoTracker™/Hoechst 33342), mitochondrial membrane potential (JC-1), and apoptosis/necrosis (AO/PI) were assessed. Clonogenic assays evaluated long-term proliferative capacity. Lastly, irritation score was examined using the HET-CAM assay at 300 µM. Results: THY produced a dose-dependent viability decrease in both lines, with HGF-1 viability remaining ≥75% and Detroit-562 reduced to ~68% at 300 µM. Morphology, mitochondrial staining, JC-1 ratios, and AO/PI imaging showed progressive apoptotic features, more evident in Detroit-562 cells. Clonogenic capacity increased slightly in HGF-1 at 100 µM and declined to ~75% at 300 µM, whereas Detroit-562 colonies decreased from ~68% to ~40% across the dose range. Additionally, THY (300 µM) showed no irritation in the HET-CAM assay. Conclusions: THY demonstrated acceptable cytocompatibility in gingival fibroblasts, stronger inhibitory effects on carcinoma cells at higher concentrations, and no acute irritation in ovo. These findings support THY’s safe use within defined concentration limits and justify further evaluation in advanced oral tissue models.

18 September 2026 in Dentistry Journal
Verified
Journal Article
Open access
PDF file
MAmhd kher alsaeyd ahmad
mhd kher alsaeyd ahmad
Stefania DinuStefania Dinu
Stefania Dinu
SDStefania Irina Dumitrel
Stefania Irina Dumitrel
RPRamona Amina Popovici
Ramona Amina Popovici
DCDoina Chioran
Doina Chioran
Background: Thymol has been considered a possible bioactive phytocompound in dentistry due to its antimicrobial, antibiofilm, antifungal and anti-inflammatory properties. The current narrative review aims to critically review the present evidence on biological properties, mechanism of action, formulations and applications of thymol in preventive dentistry, periodontics, endodontics, prosthodontics and emerging dental materials and delivery systems, highlighting the current limitations and future perspectives. Methods: A literature search was carried out on PubMed, Scopus, ScienceDirect and Google Scholar databases. The search included publications related to thymol and its applications in oral health and dentistry. Results: The most recent evidence supports the adjunctive use of thymol in preventive and periodontal oral-care products, particularly in essential oil-based formulations. Moreover, recent advances in nanoformulations and dental materials suggest that its therapeutic potential can be further improved by optimized delivery systems. Conclusions: Thymol is a naturally occurring active compound that offers numerous benefits in various dental applications due to its multifaceted properties and safety profile. Preliminary and clinical evidence is encouraging, but more standardized clinical studies are needed to better define its long-term efficacy, optimal formulations, therapeutic concentrations, and clinical applicability in dentistry.

25 September 2025 in Proceedings
Verified
Conference Paper
Open access
PDF file
SDStefania Irina Dumitrel
Stefania Irina Dumitrel
ACAndreea Cristea
Andreea Cristea
ASAndreea Smeu
Andreea Smeu
SLSergio Liga
Sergio Liga
CRISTINA ADRIANA DEHELEANCRISTINA ADRIANA DEHELEAN
CRISTINA ADRIANA DEHELEAN
Cutaneous melanoma (CM) is one of the most aggressive and lethal forms of skin cancer, characterized by a high rate of proliferation, marked local invasion, and high metastatic potential